Join us for ongoing discussions with our clinician-bloggers,
Paul Sax, MD
HIV and ID Observations
An ongoing dialogue on HIV/AIDS, infectious diseases,
all matters medical, and some not so medical
Recent Posts
Dr. Thomas O’Brien — Expert in Antimicrobial Resistance and Giant in His Field (Literally) • December 12, 2024
Dr. Thomas (Tom) O’Brien was born in January 1929, in between the discovery of penicillin (September 1928) and the publication of the findings in a medical journal (May 1929). As noted by his longtime mentee Dr. John Stelling, Tom physically embodied the antibiotic era — quite appropriate for someone best known for his groundbreaking work […]
2021-2022
Chief Resident Panel:
Abdullah Al‑abcha, MD
Mikita Arora, MD
Madiha Khan, DO
Mikita Arora, MD
Khalid A. Shalaby, MBBCh
Brandon Temte, DO
Insights on Residency Training
Notes from chief residents in family and internal medicine
Recent Posts
Developing Resident Educators • August 19, 2022 • Brandon Temte, DO
We currently find ourselves at the start of another academic year. By this time in August, many medical trainees are settling into new roles. Recently graduated medical students are getting used to hearing Dr. before their name. New senior residents who were interns a short time ago now find themselves leaders of their own teams. […]
Follow us on:
Apple Podcasts
YouTube
Spotify
Clinical Conversations
This podcast features lively interviews, concise summaries, and expert commentary that busy clinicians need to stay current and improve patient care.
Recent Posts
Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 • September 2, 2022
A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK. In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote […]
The post Podcast 298: COPD exacerbations — 7 days of antibiotics versus 2 first appeared on Clinical Conversations.The views and opinions expressed in these blogs are not necessarily those of NEJM Journal Watch or NEJM Group.
NEJM Journal Watch — Recent Infectious Diseases Articles- How Serious Is Artemisinin Partial Resistance in African Malaria Parasites?
- Observations from ID and Beyond: Who's Going to Get Lenacapavir for HIV Prevention?
- Can We Shorten the Duration of Antibiotic Treatment for Bacteremia?
- Rifampin and Gentamicin for Staphylococcal Prosthetic Valve Endocarditis: Strictly Necessary?
- Gauging Risk for Liver Cancer: Hepatitis B Viral Load Might Be a Clue
- NEJM Journal Watch — Recent General Medicine Articles